Index of reports
> Cases with Pulmonary Haemorrhage (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Curosurf (Poractant Alfa) where reactions include pulmonary haemorrhage. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Curosurf side effects in
Reported by a physician from Germany on 2012-07-11
Patient:
Reactions: Pulmonary Haemorrhage
Adverse event resulted in: death
Drug(s) suspected as cause:
Curosurf
Possible Curosurf side effects in male
Reported by a health professional (non-physician/pharmacist) from Finland on 2012-04-18
Patient: male
Reactions: Drug Administered AT Inappropriate Site, Pulmonary Haemorrhage, Swelling, Injection Site Swelling, Fluid Retention
Drug(s) suspected as cause:
Numeta G13e
Start date: 2012-02-20
Curosurf
Other drugs received by patient: Tomycin; Penicillin G
Possible Curosurf side effects in male
Reported by a physician from China on 2012-01-04
Patient: male
Reactions: Pulmonary Haemorrhage, Disseminated Intravascular Coagulation
Drug(s) suspected as cause:
Curosurf
Other drugs received by patient: Haemocoagulase (Haemocoagulase); Cefotiam (Cefotiam); Furbencillin Sodium (NO Pref. Name); Antiinfectives (Antiinfectives); Vitamin K NOS (Vitamin K Nos)
Possible Curosurf side effects in male
Reported by a physician from China on 2012-01-04
Patient: male
Reactions: LOW Birth Weight Baby, Anaemia Neonatal, Neonatal Respiratory Distress Syndrome, Metabolic Acidosis, Neonatal Pneumonia, Disseminated Intravascular Coagulation, Hyperglycaemia, Jaundice Neonatal, Pulmonary Haemorrhage, Cardio-Respiratory Arrest, Hypocalcaemia, Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Piperacillin W / Sulbactam Sodium (NO Pref. Name)
Dosage: daily dose 0.18 grams;twice a day
Indication: Pneumonia
Start date: 2011-09-19
End date: 2011-09-23
Curosurf
Dosage: daily dose 240 milligrams;daily
Indication: Neonatal Respiratory Distress Syndrome
Start date: 2011-09-19
End date: 2011-09-20
Other drugs received by patient: Haemocoagulase (Haemocoagulase); Etamsilate (Etamsilate); Phenobarbital TAB; Cefodizime (Cefodizime)
|